Page last updated: 2024-11-04

sobuzoxane and Anorexia

sobuzoxane has been researched along with Anorexia in 3 studies

sobuzoxane: used in treatment of leukemia L1210

Anorexia: The lack or loss of APPETITE accompanied by an aversion to food and the inability to eat. It is the defining characteristic of the disorder ANOREXIA NERVOSA.

Research Excerpts

ExcerptRelevanceReference
"Leukopenia was observed in 72."1.28[Late phase II study of MST-16 (sobuzoxane) on malignant lymphoma]. ( Inagaki, J; Kamiya, O; Kobayashi, M; Mitomo, Y; Nishiwaki, H; Oguri, T; Ohno, R; Tanaka, M; Yamada, K; Yokomaku, S, 1991)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Masaoka, T2
Kageyama, T1
Tatsumi, N1
Akasaka, K1
Yonezawa, T1
Sugiyama, H1
Kitani, T1
Yasunaga, K1
Horiuchi, A1
Nakayama, S1
Tominaga, N1
Teshima, H1
Hiraoka, A1
Ariyoshi, Y1
Suzuki, H1
Kimura, I1
Ohnoshi, T1
Hayashi, K1
Arima, T1
Yamada, K1
Ohno, R1
Oguri, T1
Kamiya, O1
Yokomaku, S1
Kobayashi, M1
Nishiwaki, H1
Tanaka, M1
Inagaki, J1
Mitomo, Y1

Trials

1 trial available for sobuzoxane and Anorexia

ArticleYear
[Late phase II study of MST-16 (sobuzoxane) efficacy for malignant lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents; Drug Administration Schedule; Drug

1992

Other Studies

2 other studies available for sobuzoxane and Anorexia

ArticleYear
[Early phase II study of MST-16 (sobuzoxane) on malignant lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:14

    Topics: Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents; Drug Administration Schedule; Drug

1991
[Late phase II study of MST-16 (sobuzoxane) on malignant lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:14

    Topics: Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents; Drug Evaluation; Female; Hodgkin Di

1991